CSIMarket
 


Neuropathix Inc.  (TYGS)
Other Ticker:  
 

Cumulative Neuropathix's Quick Ratio for Trailing Twelve Months Period

TYGS's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

TYGS Quick Ratio for Trailing Twelve Months Period

(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
Y / Y Current Liabilities Growth 47.4 % 17.18 % 26.63 % 15.15 % 53.7 %
Y / Y Cash & cash equivalent Growth -64.94 % -15.89 % -28.02 % -58.83 % 158.39 %
Quick Ratio for Trailing Twelve Months Period 0.02 0.04 0.05 0.05 0.06
Total Ranking # 5830 # 5487 # 4575 # 4533 # 4663
Seq. Current Liabilities Growth 20.63 % 12.6 % 5.29 % 3.06 % -4.1 %
Seq. Cash & cash equivalent Growth 263.79 % 44.33 % -66.66 % -79.97 % 772.7 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Mar 31 2022
On the trailing twelve months basis Due to growth in Current Liabilities in the I. Quarter to $4 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 0.02 below Neuropathix Inc. average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 592 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Neuropathix. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about TYGS
Quick Ratio TYGS in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 593
Sector # 1204
S&P 500 # 5637


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
2.56 0.8 0.02
(Dec 31 2018)   (Mar 31 2022)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2022, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Rapid Therapeutic Science Laboratories Inc   0.05 
Neuropathix Inc.  0.05 
Bioadaptives Inc   0.04 
Oncotelic Therapeutics Inc   0.04 
Sunwin Stevia International Inc.  0.04 
Northwest Biotherapeutics inc  0.03 
Sangui Biotech International Inc  0.03 
Generex Biotechnology Corp  0.03 
Provectus Biopharmaceuticals Inc   0.02 
Musclepharm Corporation  0.02 
Wellness Center Usa Inc  0.02 
Biostax Corp  0.02 
Globestar Therapeutics Corporation  0.02 
American Bio Medica Corporation  0.02 
Propanc Biopharma Inc   0.02 
Integrated Biopharma Inc  0.02 
Kaya Holdings Inc  0.02 
Lifecore Biomedical Inc   0.01 
Skinvisible Inc   0.01 
Actavia Life Sciences Inc   0.01 
Intellipharmaceutics International Inc   0.01 
Cell Source Inc   0.01 
Regen Biopharma Inc  0.01 
Novaccess Global Inc   0.01 
Cardax Inc 0.00 
Earth Science Tech Inc 0.00 
Cannapharmarx Inc 0.00 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com